| Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial). | |
| | |
MedLine Citation:
|
PMID: 16490423 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The DANAMI-2 trial showed a 40% decrease in the composite end point with primary coronary angioplasty versus fibrinolysis. This result was primarily driven by a decrease in reinfarction, with no significant difference in mortality or stroke rates. The objective of this study was to determine the prognostic value of the sum ST-segment elevation (SigmaST) on baseline electrocardiography in patients who were randomized to receive primary coronary angioplasty versus fibrinolysis. In the DANAMI-2, 1,450 patients had baseline ST-segment deviation measurements and were assigned to quartiles according to SigmaST: 0 to 6.5, 7.0 to 9.5, 10.0 to 14.5, and 15.0 to 70.5 mm. The composite and component end-point rates at 30 days were determined for each quartile and chi-square for trend statistic was used to compare end-point rates across quartiles of SigmaST. The composite end point occurred more often with increasing SigmaST (p = 0.05). With regard to component end points, only mortality increased significantly with SigmaST (p = 0.03), whereas reinfarction and stroke rates did not. By multivariate analysis, only SigmaST and age were independent predictors of mortality. The relative benefit of primary coronary angioplasty was similar for all SigmaST quartiles. In conclusion, the magnitude of SigmaST correlates with increased mortality at 30 days, thus driving the composite end point rate. Regardless of SigmaST, patients had a lower composite end-point rate with primary coronary angioplasty than with fibrinolysis. |
| | |
Authors:
|
Maria Sejersten; Rasmus S Ripa; Charles Maynard; Galen S Wagner; Henning Rud Andersen; Peer Grande; Leif Spange Mortensen; Peter Clemmensen |
Related Documents
:
|
10860173 - Primary angioplasty for acute myocardial infarction in the elderly. 2210593 - Excimer laser coronary angioplasty: american multicenter experience. 21692973 - Left stellate ganglion blockade for the management of drug-resistant electrical storm. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2006-01-06 |
Journal Detail:
|
Title: The American journal of cardiology Volume: 97 ISSN: 0002-9149 ISO Abbreviation: Am. J. Cardiol. Publication Date: 2006 Mar |
Date Detail:
|
Created Date: 2006-02-21 Completed Date: 2006-04-18 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 611-6 Citation Subset: AIM; IM |
Affiliation:
|
Heart Centre, Department of Cardiology, Rigshospitalet, University Hospital, Copenhagen, Denmark. m.sejersten@webspeed.dk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angioplasty, Transluminal, Percutaneous Coronary* Coronary Disease / drug therapy, mortality, physiopathology*, therapy* Electrocardiography Female Fibrinolytic Agents / therapeutic use* Follow-Up Studies Heart Conduction System / physiopathology* Humans Male Middle Aged Myocardial Infarction / physiopathology, therapy Predictive Value of Tests Prognosis Randomized Controlled Trials as Topic Stroke / etiology, mortality Survival Rate Thrombolytic Therapy* / methods Time Factors Tissue Plasminogen Activator / therapeutic use Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; EC 3.4.21.68/Tissue Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo ...
Next Document: Effect of reactive hyperemia after coronary recanalization on myocardial tissue reperfusion by throm...